Peter Strumph

Peter Strumph

Company: Parvus Therapeutics

Job title: CEO


Paving the Way to IND Approval: The Development of Navacims ™ & Challenges on the Way 4:45 pm

Employing Navacims™ to reprogram disease-causing T cells into disease-regulating Tregs Sharing experiences from drug development and the path to the clinic Highlighting investor and partner sentiments to accelerate the formation of relationships and investmentRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.